Scandion Oncology A/S 8VY.F Stock
Scandion Oncology A/S Price Chart
Scandion Oncology A/S 8VY.F Financial and Trading Overview
| Scandion Oncology A/S stock price | 0.21 EUR |
| Previous Close | 0.12 EUR |
| Open | 0.12 EUR |
| Bid | 0.12 EUR x N/A |
| Ask | 0.5 EUR x N/A |
| Day's Range | 0.12 - 0.12 EUR |
| 52 Week Range | 0.09 - 0.28 EUR |
| Volume | 500 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 6.41M EUR |
| Beta (5Y Monthly) | 0.913 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8VY.F Valuation Measures
| Enterprise Value | -30660336 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.967336 |
| Price/Book (mrq) | 0.11980677 |
| Enterprise Value/Revenue | -62.065 |
| Enterprise Value/EBITDA | 0.591 |
Trading Information
Scandion Oncology A/S Stock Price History
| Beta (5Y Monthly) | 0.913 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.28 EUR |
| 52 Week Low | 0.09 EUR |
| 50-Day Moving Average | 0.12 EUR |
| 200-Day Moving Average | 0.14 EUR |
8VY.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 40.71M |
| Float | 38.48M |
| Short Ratio | N/A |
| % Held by Insiders | 5.31% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 5612.04% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.36% |
| Return on Equity (ttm) | -68.74% |
Income Statement
| Revenue (ttm) | 494K EUR |
| Revenue Per Share (ttm) | 0.05 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -51842000 EUR |
| Net Income Avi to Common (ttm) | -43902000 EUR |
| Diluted EPS (ttm) | -0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 36.33M EUR |
| Total Cash Per Share (mrq) | 0.89 EUR |
| Total Debt (mrq) | 622K EUR |
| Total Debt/Equity (mrq) | 1.48 EUR |
| Current Ratio (mrq) | 5.571 |
| Book Value Per Share (mrq) | 1.035 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -53965000 EUR |
| Levered Free Cash Flow (ttm) | -42681876 EUR |
Profile of Scandion Oncology A/S
| Country | Germany |
| State | N/A |
| City | Copenhagen |
| Address | Symbion |
| ZIP | 2100 |
| Phone | 45 38 10 20 17 |
| Website | https://www.scandiononcology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Scandion Oncology A/S, a clinical-stage biotechnology company, develops medicines for the treatment of chemotherapy resistance. Its lead product candidate includes the SCO-101, an oral drug that is in clinical Phase Ib and Phase II studies in cancer patients. The company's other product candidate is SCO-201, which is in preclinical trial for the treatment of solid tumors. Scandion Oncology A/S was incorporated in 2017 and is headquartered in Copenhagen, Denmark.
Q&A For Scandion Oncology A/S Stock
What is a current 8VY.F stock price?
Scandion Oncology A/S 8VY.F stock price today per share is 0.21 EUR.
How to purchase Scandion Oncology A/S stock?
You can buy 8VY.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scandion Oncology A/S?
The stock symbol or ticker of Scandion Oncology A/S is 8VY.F.
Which industry does the Scandion Oncology A/S company belong to?
The Scandion Oncology A/S industry is Biotechnology.
How many shares does Scandion Oncology A/S have in circulation?
The max supply of Scandion Oncology A/S shares is 43.52M.
What is Scandion Oncology A/S Price to Earnings Ratio (PE Ratio)?
Scandion Oncology A/S PE Ratio is now.
What was Scandion Oncology A/S earnings per share over the trailing 12 months (TTM)?
Scandion Oncology A/S EPS is -0.13 EUR over the trailing 12 months.
Which sector does the Scandion Oncology A/S company belong to?
The Scandion Oncology A/S sector is Healthcare.